Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Mihir Bhatta"'
Autor:
Rohini Chakrabarti, Debdutta Agasty, Agniva Majumdar, Rounik Talukdar, Mihir Bhatta, Subrata Biswas, Shanta Dutta
Publikováno v:
Health Promotion Perspectives, Vol 13, Iss 4, Pp 243-253 (2023)
Background: The burden of the COVID-19 pandemic on healthcare systems worldwide has been compromising the progress made in the fight against HIV. This paper aims to determine how the COVID-19 pandemic has impacted HIV comprehensive care service deliv
Externí odkaz:
https://doaj.org/article/290fc547d37c4834aa24662fc5720bfa
Autor:
Mihir Bhatta, Agniva Majumdar, Sitikantha Banerjee, Piyali Ghosh, Subrata Biswas, Shanta Dutta
Publikováno v:
JMIR Research Protocols, Vol 12, p e43722 (2023)
BackgroundRespondent-driven sampling (RDS) is a nonprobability sampling technique that allows the extrapolation of its outcome to the target population. This approach is typically used to overcome the difficulties in studying hidden or difficult-to-r
Externí odkaz:
https://doaj.org/article/9f774712668548088398844273f93a40
Autor:
Mihir Bhatta, Agniva Majumdar, Utsha Ghosh, Piyali Ghosh, Papiya Banerji, Santhakumar Aridoss, Abhisek Royal, Subrata Biswas, Bhumika Tumkur Venkatesh, Rajatsuvra Adhikary, Shanta Dutta
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0279048 (2023)
BackgroundSexually transmitted infections (STIs) are one of the leading causes of health, and economic burdens in the developing world, leading to considerable morbidity, mortality, and stigma. The incidence and prevalence of the four curable STIs vi
Externí odkaz:
https://doaj.org/article/ca7d931afe6545ba897d9238938a18ef
Publikováno v:
BMC Pregnancy and Childbirth, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background In India, preventing mother-to-child transmission (PMTCT) of Human Immunodeficiency Virus (HIV) remains one of the foremost challenge in community health. Countrywide MTCT of HIV is estimated to be > 10,000 annually. Aims of prese
Externí odkaz:
https://doaj.org/article/8a0bc6e70df040f79b4a79dabd99d268
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
COVID-19 is an international public health emergency in need of effective and safe vaccines for SARS-CoV-2. A systematic review has been done to analyze the availability, development and status of new COVID-19 vaccine candidates as well as the status
Externí odkaz:
https://doaj.org/article/d5d85b0bb33743c18ad5b796c828aecd
Autor:
Kaliyaperumal Rekha, Nalok Dutta, Muthu Thiruvengadam, Mohammad Ali Shariati, Muhammad Usman Khan, Muhammad Usman, Mihir Bhatta, Kunal Ghosh, Shaheer Arif, Muhammad Naeem
Publikováno v:
Nanomaterials in Clinical Therapeutics. :441-458
Autor:
Mihir Bhatta, Agniva Majumdar, Utsha Ghosh, Piyali Ghosh, Papiya Banerji, Santhakumar Aridoss, Abhisek Royal, Subrata Biswas, Bhumika Tumkur Venkatesh, Rajatsuvra Adhikary, Shanta Dutta
Background Sexually transmitted infections (STIs) are one of the leading causes of health, and economic burdens in the developing world, leading to considerable morbidity, mortality, and stigma. The incidence and prevalence of the four curable STIs v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73e7bb46a34b44167fa31394f2e02be6
https://doi.org/10.1101/2022.12.04.22282962
https://doi.org/10.1101/2022.12.04.22282962
Autor:
Mihir BHATTA, Agniva Majumdar, Sitikanta Banerjee, Piayli Ghosh, Subrata Biswas, Shanta Dutta
BACKGROUND The Respondent-driven Sampling (RDS) method is a non-probability sampling method that approximates probability sample design, allowing for extrapolating results to the target population. This method is generally used to address the limitat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0ad69bb515b951f82d4e03257a9513d
https://doi.org/10.2196/preprints.43722
https://doi.org/10.2196/preprints.43722
Autor:
Mihir BHATTA, Agniva Majumdar, Sitikanta Banerjee, Piyali Ghosh, Subrata Biswas, Shanta Dutta
Publikováno v:
JMIR Research Protocols.
Publikováno v:
Japanese journal of infectious diseases. 75(5)
To maintain the performance quality, human immunodeficiency virus (HIV) in vitro diagnostic (IVD) kits are required to be evaluated by unbiased health regulatory organizations following predefined guidelines. The World Health Organization (WHO) prequ